Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

BYD vs PEN vs ISRG vs CZR vs SYK

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BYD
Boyd Gaming Corporation

Gambling, Resorts & Casinos

Consumer CyclicalNYSE • US
Market Cap$6.42B
5Y Perf.+300.4%
PEN
Penumbra, Inc.

Medical - Devices

HealthcareNYSE • US
Market Cap$12.77B
5Y Perf.+86.9%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$161.07B
5Y Perf.+132.8%
CZR
Caesars Entertainment, Inc.

Gambling, Resorts & Casinos

Consumer CyclicalNASDAQ • US
Market Cap$5.66B
5Y Perf.+146.2%
SYK
Stryker Corporation

Medical - Devices

HealthcareNYSE • US
Market Cap$112.69B
5Y Perf.+45.8%

BYD vs PEN vs ISRG vs CZR vs SYK — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BYD logoBYD
PEN logoPEN
ISRG logoISRG
CZR logoCZR
SYK logoSYK
IndustryGambling, Resorts & CasinosMedical - DevicesMedical - Instruments & SuppliesGambling, Resorts & CasinosMedical - Devices
Market Cap$6.42B$12.77B$161.07B$5.66B$112.69B
Revenue (TTM)$4.09B$1.45B$10.58B$11.56B$25.12B
Net Income (TTM)$1.84B$171M$2.98B$-485M$3.25B
Gross Margin42.1%67.4%66.3%43.9%63.5%
Operating Margin21.4%12.9%30.5%17.8%22.4%
Forward P/E11.9x65.2x43.3x19.6x
Total Debt$3.27B$220M$303M$26.34B$14.86B
Cash & Equiv.$353M$187M$3.37B$887M$4.01B

BYD vs PEN vs ISRG vs CZR vs SYKLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BYD
PEN
ISRG
CZR
SYK
StockMay 20May 26Return
Boyd Gaming Corpora… (BYD)100400.4+300.4%
Penumbra, Inc. (PEN)100186.9+86.9%
Intuitive Surgical,… (ISRG)100232.8+132.8%
Caesars Entertainme… (CZR)100246.2+146.2%
Stryker Corporation (SYK)100145.8+45.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: BYD vs PEN vs ISRG vs CZR vs SYK

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: BYD leads in 4 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Penumbra, Inc. is the stronger pick specifically for capital preservation and lower volatility. ISRG and SYK also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
BYD
Boyd Gaming Corporation
The Value Play

BYD carries the broadest edge in this set and is the clearest fit for value and quality.

  • Lower P/E (11.9x vs 43.3x)
  • 45.0% margin vs CZR's -4.2%
  • +21.2% vs SYK's -22.5%
  • 27.9% ROA vs CZR's -1.5%, ROIC 12.3% vs 5.4%
Best for: value and quality
PEN
Penumbra, Inc.
The Growth Play

PEN is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.

  • Rev growth 17.5%, EPS growth 11.6%, 3Y rev CAGR 18.3%
  • Lower volatility, beta 0.25, Low D/E 15.4%, current ratio 6.64x
  • Beta 0.25 vs CZR's 1.27, lower leverage
Best for: growth exposure and sleep-well-at-night
ISRG
Intuitive Surgical, Inc.
The Long-Run Compounder

ISRG ranks third and is worth considering specifically for long-term compounding.

  • 5.5% 10Y total return vs BYD's 365.7%
  • 20.5% revenue growth vs CZR's 2.1%
Best for: long-term compounding
CZR
Caesars Entertainment, Inc.
The Consumer Cyclical Pick

Among these 5 stocks, CZR doesn't own a clear edge in any measured category.

Best for: consumer cyclical exposure
SYK
Stryker Corporation
The Income Pick

SYK is the clearest fit if your priority is income & stability and valuation efficiency.

  • Dividend streak 34 yrs, beta 0.55, yield 1.1%
  • PEG 1.32 vs ISRG's 1.99
  • Beta 0.55, yield 1.1%, current ratio 1.89x
  • 1.1% yield, 34-year raise streak, vs BYD's 0.8%, (3 stocks pay no dividend)
Best for: income & stability and valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthISRG logoISRG20.5% revenue growth vs CZR's 2.1%
ValueBYD logoBYDLower P/E (11.9x vs 43.3x)
Quality / MarginsBYD logoBYD45.0% margin vs CZR's -4.2%
Stability / SafetyPEN logoPENBeta 0.25 vs CZR's 1.27, lower leverage
DividendsSYK logoSYK1.1% yield, 34-year raise streak, vs BYD's 0.8%, (3 stocks pay no dividend)
Momentum (1Y)BYD logoBYD+21.2% vs SYK's -22.5%
Efficiency (ROA)BYD logoBYD27.9% ROA vs CZR's -1.5%, ROIC 12.3% vs 5.4%

BYD vs PEN vs ISRG vs CZR vs SYK — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BYDBoyd Gaming Corporation
FY 2025
Casino
78.0%$2.6B
Food and Beverage
9.2%$310M
Occupancy
5.7%$191M
Product and Service, Other
4.3%$145M
Management Fee
2.9%$99M
PENPenumbra, Inc.
FY 2022
Peripheral Vascular
59.0%$499M
Neuro
41.0%$348M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B
CZRCaesars Entertainment, Inc.
FY 2025
Casino
64.4%$6.6B
Hotel, Owned
18.9%$1.9B
Food and Beverage
16.7%$1.7B
SYKStryker Corporation
FY 2025
MedSurg
62.3%$15.6B
Orthopaedics
37.7%$9.5B

BYD vs PEN vs ISRG vs CZR vs SYK — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGPEN

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 3 of 6 comparable metrics.

SYK is the larger business by revenue, generating $25.1B annually — 17.3x PEN's $1.5B. BYD is the more profitable business, keeping 45.0% of every revenue dollar as net income compared to CZR's -4.2%. On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricBYD logoBYDBoyd Gaming Corpo…PEN logoPENPenumbra, Inc.ISRG logoISRGIntuitive Surgica…CZR logoCZRCaesars Entertain…SYK logoSYKStryker Corporati…
RevenueTrailing 12 months$4.1B$1.5B$10.6B$11.6B$25.1B
EBITDAEarnings before interest/tax$1.2B$200M$3.8B$3.5B$6.3B
Net IncomeAfter-tax profit$1.8B$171M$3.0B-$485M$3.2B
Free Cash FlowCash after capex$388M$213M$2.8B$538M$4.3B
Gross MarginGross profit ÷ Revenue+42.1%+67.4%+66.3%+43.9%+63.5%
Operating MarginEBIT ÷ Revenue+21.4%+12.9%+30.5%+17.8%+22.4%
Net MarginNet income ÷ Revenue+45.0%+11.8%+28.2%-4.2%+12.9%
FCF MarginFCF ÷ Revenue+9.5%+14.6%+26.8%+4.7%+17.1%
Rev. Growth (YoY)Latest quarter vs prior year+2.0%+15.6%+23.0%+2.7%+11.4%
EPS Growth (YoY)Latest quarter vs prior year-6.8%-18.0%+18.8%+11.1%+56.0%
ISRG leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

CZR leads this category, winning 4 of 7 comparable metrics.

At 3.8x trailing earnings, BYD trades at a 95% valuation discount to PEN's 71.8x P/E. Adjusting for growth (PEG ratio), SYK offers better value at 2.36x vs ISRG's 2.65x — a lower PEG means you pay less per unit of expected earnings growth.

MetricBYD logoBYDBoyd Gaming Corpo…PEN logoPENPenumbra, Inc.ISRG logoISRGIntuitive Surgica…CZR logoCZRCaesars Entertain…SYK logoSYKStryker Corporati…
Market CapShares × price$6.4B$12.8B$161.1B$5.7B$112.7B
Enterprise ValueMkt cap + debt − cash$9.3B$12.8B$158.0B$31.1B$123.5B
Trailing P/EPrice ÷ TTM EPS3.78x71.82x57.62x-11.48x35.03x
Forward P/EPrice ÷ next-FY EPS est.11.93x65.17x43.35x19.62x
PEG RatioP/E ÷ EPS growth rate2.65x2.36x
EV / EBITDAEnterprise value multiple7.91x61.91x43.62x8.90x20.31x
Price / SalesMarket cap ÷ Revenue1.57x9.09x16.00x0.49x4.49x
Price / BookPrice ÷ Book value/share2.67x8.93x9.17x1.57x5.02x
Price / FCFMarket cap ÷ FCF16.52x72.97x64.67x10.88x26.31x
CZR leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 4 of 9 comparable metrics.

BYD delivers a 91.8% return on equity — every $100 of shareholder capital generates $92 in annual profit, vs $-13 for CZR. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to CZR's 7.15x. On the Piotroski fundamental quality scale (0–9), PEN scores 7/9 vs CZR's 5/9, reflecting strong financial health.

MetricBYD logoBYDBoyd Gaming Corpo…PEN logoPENPenumbra, Inc.ISRG logoISRGIntuitive Surgica…CZR logoCZRCaesars Entertain…SYK logoSYKStryker Corporati…
ROE (TTM)Return on equity+91.8%+12.3%+16.9%-12.6%+15.0%
ROA (TTM)Return on assets+27.9%+9.6%+14.8%-1.5%+6.9%
ROICReturn on invested capital+12.3%+11.3%+15.0%+5.4%+11.4%
ROCEReturn on capital employed+15.1%+12.5%+16.5%+7.0%+13.0%
Piotroski ScoreFundamental quality 0–957656
Debt / EquityFinancial leverage1.25x0.15x0.02x7.15x0.66x
Net DebtTotal debt minus cash$2.9B$33M-$3.1B$25.5B$10.8B
Cash & Equiv.Liquid assets$353M$187M$3.4B$887M$4.0B
Total DebtShort + long-term debt$3.3B$220M$303M$26.3B$14.9B
Interest CoverageEBIT ÷ Interest expense15.78x304.65x0.90x6.72x
ISRG leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

ISRG leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ISRG five years ago would be worth $15,873 today (with dividends reinvested), compared to $2,627 for CZR. Over the past 12 months, BYD leads with a +21.2% total return vs SYK's -22.5%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.4% vs CZR's -15.0% — a key indicator of consistent wealth creation.

MetricBYD logoBYDBoyd Gaming Corpo…PEN logoPENPenumbra, Inc.ISRG logoISRGIntuitive Surgica…CZR logoCZRCaesars Entertain…SYK logoSYKStryker Corporati…
YTD ReturnYear-to-date-0.9%+4.9%-19.3%+17.9%-15.2%
1-Year ReturnPast 12 months+21.2%+12.2%-15.4%+2.5%-22.5%
3-Year ReturnCumulative with dividends+24.2%+4.5%+49.6%-38.6%+5.5%
5-Year ReturnCumulative with dividends+30.1%+19.6%+58.7%-73.7%+21.5%
10-Year ReturnCumulative with dividends+365.7%+505.9%+554.2%+302.6%+187.1%
CAGR (3Y)Annualised 3-year return+7.5%+1.5%+14.4%-15.0%+1.8%
ISRG leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — BYD and PEN each lead in 1 of 2 comparable metrics.

PEN is the less volatile stock with a 0.25 beta — it tends to amplify market swings less than CZR's 1.27 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BYD currently trades 94.7% from its 52-week high vs SYK's 72.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBYD logoBYDBoyd Gaming Corpo…PEN logoPENPenumbra, Inc.ISRG logoISRGIntuitive Surgica…CZR logoCZRCaesars Entertain…SYK logoSYKStryker Corporati…
Beta (5Y)Sensitivity to S&P 5000.84x0.23x1.00x1.24x0.52x
52-Week HighHighest price in past year$89.96$362.41$603.88$31.58$404.87
52-Week LowLowest price in past year$69.01$221.26$427.84$17.95$289.91
% of 52W HighCurrent price vs 52-week peak+94.7%+89.6%+75.1%+88.0%+72.7%
RSI (14)Momentum oscillator 0–10049.736.742.454.524.3
Avg Volume (50D)Average daily shares traded932K544K1.8M4.6M2.1M
Evenly matched — BYD and PEN each lead in 1 of 2 comparable metrics.

Analyst Outlook

SYK leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: BYD as "Buy", PEN as "Hold", ISRG as "Buy", CZR as "Buy", SYK as "Buy". Consensus price targets imply 37.3% upside for ISRG (target: $623) vs 10.0% for CZR (target: $31). For income investors, SYK offers the higher dividend yield at 1.14% vs BYD's 0.84%.

MetricBYD logoBYDBoyd Gaming Corpo…PEN logoPENPenumbra, Inc.ISRG logoISRGIntuitive Surgica…CZR logoCZRCaesars Entertain…SYK logoSYKStryker Corporati…
Analyst RatingConsensus buy/hold/sellBuyHoldBuyBuyBuy
Price TargetConsensus 12-month target$95.00$371.92$622.60$30.57$403.69
# AnalystsCovering analysts3822553050
Dividend YieldAnnual dividend ÷ price+0.8%+1.1%
Dividend StreakConsecutive years of raises4034
Dividend / ShareAnnual DPS$0.71$3.36
Buyback YieldShare repurchases ÷ mkt cap+12.1%0.0%+1.4%+4.0%0.0%
SYK leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

ISRG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CZR leads in 1 (Valuation Metrics). 1 tied.

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 3 of 6 categories
Loading custom metrics...

BYD vs PEN vs ISRG vs CZR vs SYK: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is BYD or PEN or ISRG or CZR or SYK a better buy right now?

For growth investors, Intuitive Surgical, Inc.

(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus 2. 1% for Caesars Entertainment, Inc. (CZR). Boyd Gaming Corporation (BYD) offers the better valuation at 3. 8x trailing P/E (11. 9x forward), making it the more compelling value choice. Analysts rate Boyd Gaming Corporation (BYD) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — BYD or PEN or ISRG or CZR or SYK?

On trailing P/E, Boyd Gaming Corporation (BYD) is the cheapest at 3.

8x versus Penumbra, Inc. at 71. 8x. On forward P/E, Boyd Gaming Corporation is actually cheaper at 11. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Stryker Corporation wins at 1. 32x versus Intuitive Surgical, Inc. 's 1. 99x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — BYD or PEN or ISRG or CZR or SYK?

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +58. 7%, compared to -73. 7% for Caesars Entertainment, Inc. (CZR). Over 10 years, the gap is even starker: ISRG returned +549. 2% versus SYK's +179. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — BYD or PEN or ISRG or CZR or SYK?

By beta (market sensitivity over 5 years), Penumbra, Inc.

(PEN) is the lower-risk stock at 0. 23β versus Caesars Entertainment, Inc. 's 1. 24β — meaning CZR is approximately 440% more volatile than PEN relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 7% for Caesars Entertainment, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — BYD or PEN or ISRG or CZR or SYK?

By revenue growth (latest reported year), Intuitive Surgical, Inc.

(ISRG) is pulling ahead at 20. 5% versus 2. 1% for Caesars Entertainment, Inc. (CZR). On earnings-per-share growth, the picture is similar: Penumbra, Inc. grew EPS 1156% year-over-year, compared to -87. 6% for Caesars Entertainment, Inc.. Over a 3-year CAGR, PEN leads at 18. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — BYD or PEN or ISRG or CZR or SYK?

Boyd Gaming Corporation (BYD) is the more profitable company, earning 45.

0% net margin versus -4. 4% for Caesars Entertainment, Inc. — meaning it keeps 45. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus 13. 5% for PEN. At the gross margin level — before operating expenses — PEN leads at 67. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is BYD or PEN or ISRG or CZR or SYK more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Stryker Corporation (SYK) is the more undervalued stock at a PEG of 1. 32x versus Intuitive Surgical, Inc. 's 1. 99x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Boyd Gaming Corporation (BYD) trades at 11. 9x forward P/E versus 65. 2x for Penumbra, Inc. — 53. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ISRG: 37. 3% to $622. 60.

08

Which pays a better dividend — BYD or PEN or ISRG or CZR or SYK?

In this comparison, SYK (1.

1% yield), BYD (0. 8% yield) pay a dividend. PEN, ISRG, CZR do not pay a meaningful dividend and should not be held primarily for income.

09

Is BYD or PEN or ISRG or CZR or SYK better for a retirement portfolio?

For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

52), 1. 1% yield, +179. 2% 10Y return). Both have compounded well over 10 years (SYK: +179. 2%, CZR: +306. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between BYD and PEN and ISRG and CZR and SYK?

These companies operate in different sectors (BYD (Consumer Cyclical) and PEN (Healthcare) and ISRG (Healthcare) and CZR (Consumer Cyclical) and SYK (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: BYD is a small-cap deep-value stock; PEN is a mid-cap high-growth stock; ISRG is a mid-cap high-growth stock; CZR is a small-cap quality compounder stock; SYK is a mid-cap quality compounder stock. BYD, SYK pay a dividend while PEN, ISRG, CZR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

BYD

Quality Mega-Cap Compounder

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Net Margin > 27%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

PEN

High-Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 7%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Stocks Like

CZR

Quality Business

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Gross Margin > 26%
Run This Screen
Stocks Like

SYK

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform BYD and PEN and ISRG and CZR and SYK on the metrics below

Revenue Growth>
%
(BYD: 2.0% · PEN: 15.6%)
Net Margin>
%
(BYD: 45.0% · PEN: 11.8%)
P/E Ratio<
x
(BYD: 3.8x · PEN: 71.8x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.